Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-105300

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 1, 2016P20,000$16.1857A2,892,130IBy LP
Common StockF1Mar 1, 2016P20,000$16.1251A2,912,130IBy LP
Common StockF1Mar 1, 2016P15,972$16.942A2,928,102IBy LP
Common StockF1Mar 2, 2016P4,028$17.8565A2,932,130IBy LP
Common StockF1Mar 2, 2016P20,000$18.0764A2,952,130IBy LP
Common StockF1Mar 2, 2016P6,500$18.7669A2,958,630IBy LP
Common StockF1Mar 3, 2016P13,500$18.9096A2,972,130IBy LP
Common StockF1Mar 3, 2016P20,000$18.7244A2,992,130IBy LP
Common StockF1Mar 3, 2016P20,000$18.5453A3,012,130IBy LP
Common StockF1Mar 3, 2016P20,000$18.928A3,032,130IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses